"No age breakdown was given in the reporting of the results, which have been cast into doubt over the omission of the most at-risk age demographics.
"Former Pfizer research and development president Geoffrey Porges researchers “said he thought it was unlikely the AstraZeneca jab would get approval in the US after the company ‘tried to embellish their results’ by highlighting higher efficacy in a ‘relatively small subset of subjects in the study’”, the Financial Times reports."
www.theweek.co.uk/108791/coronavirus-age-of-oxford-vaccine-test-subjects-raises-awkward-questions
though I first read it elsewhere.
|